StonvexLoading…
StonvexStonvexStonvexCore line items from LPSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $243.74M | $312.47M | $401.98M | $514.80M |
Operating Income | $-78.70M | $-183.19M | $-111.38M | $-221.88M |
Net Income | $-67.23M | $-134.27M | $-100.44M | $-225.75M |
EPS (Diluted) | $-12.39 | $-22.70 | $-19.17 | $-3.03 |
Total Assets | $454.67M | $607.78M | $835.51M | $1.09B |
Total Liabilities | $499.16M | $675.09M | $787.38M | $1.02B |
Cash & Equivalents | $95.00M | $183.24M | $210.78M | $391.78M |
Free Cash Flow OCF − CapEx | $-42.52M | $-40.27M | $-48.42M | $-110.59M |
Shares Outstanding | 12.04M | 6.08M | 87.84M | 75.58M |